If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes... Oct 19
Zydus Cadila has received tentative approval to market 11 mg Tofacitinib Extended-Release Tablets... Oct 19
Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD... Oct 19
Glenmark received approval from ANDA for Sirolimus Tablets, a generic version of Rapamune Tablets... Oct 19
ViiV Healthcare announced CHMP issed positive opinion recommending Vocabria in combination with Rekambys and Edurant for the treatment of HIV-1 ... Oct 16
Dupixent combined with TCS in children aged 6 to 11 years with severe atopic dermatitis that is uncontrolled on topical prescription therapies... Oct 16
Sanofi and Translate Bio today announced the preclinical results of an mRNA-based vaccine candidate against SARS-CoV-2... Oct 15
... Oct 15
Glenmark being a leader in the area of respiratory has been amongst the first to launch the branded generic version for the treatment of Pulmonary ... Oct 14
A pivotal Phase 3 trial of Dupixent met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-... Oct 13
Rhizen and Curon's exclusive license agreement for Tenalisib, a dual PI3K delta & gamma inhibitor in the Greater China region.... Oct 12
Dr. Reddy’s Laboratories Ltd., today announced the launch of Cinacalcet Tablets, a generic version of Sensipar Tablets, approved by the USFDA... Oct 01
Pfizer Inc. today announced that its investigational gene therapy candidate being developed to treat Duchenne muscular dystrophy ... Oct 01
-Advertisements-
.jpeg)
Sunday, April 06, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
